[A reinstatement of clofibrate appears justified].
D002994:Clofibrate / Q000009:adverse effects* / Q000627:therapeutic use; D005860:Germany, West; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D007880:Legislation, Drug; D008055:Lipids / Q000097:blood
D008055:Lipids; D002994:Clofibrate
Eine Wiederzulassung erscheint gerechtfertigt.